These three ERCC2 SNPs are found to be associated with a reduced repair of aromatic DNA adducts [21], [22] and an increasing risk of lung cancer [23], [24], bladder cancer [25], esophageal squamous cell carcinoma (ESCC) [26] and head and neck cancer [27]. This evidence concerns the gene ERCC2 and esophageal squamous cell carcinoma.